Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Am Chem Soc. 2015 Nov 18;137(47):14854–14857. doi: 10.1021/jacs.5b10182

Figure 2.

Figure 2

(A) Kynurenine inhibition by 2 (10 μM) in comparison to (D)-1-MT (1 mM) and an untreated control (B) Immunoblotting of the pharmacological inhibition of human IDO in SKOV3 cells. Cells were treated with 10 μM platinum concentrations for 1, 2 and C16-Pt-Suc.